A
Alasdair M. Barr
Researcher at University of British Columbia
Publications - 231
Citations - 7960
Alasdair M. Barr is an academic researcher from University of British Columbia. The author has contributed to research in topics: Antipsychotic & Clozapine. The author has an hindex of 45, co-authored 211 publications receiving 6915 citations. Previous affiliations of Alasdair M. Barr include UBC Hospital & Scripps Research Institute.
Papers
More filters
Journal ArticleDOI
Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review.
David D. Kim,Alasdair M. Barr,Yunsun Chung,Jessica W. Y. Yuen,Mahyar Etminan,Bruce Carleton,Randall F. White,William G. Honer,Ric M. Procyshyn +8 more
TL;DR: A systematic review of reports of paradoxical induction of tics by first- and second-generation antipsychotic users found tics can be a disturbing adverse effect of antipsychotics and Clinicians need to be particularly vigilant when initiating and modifying antipsychosis regimens.
Journal ArticleDOI
A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
Journal ArticleDOI
Anterior internal capsule volumes increase in patients with schizophrenia switched from typical antipsychotics to olanzapine.
Vina M. Goghari,Donna J. Lang,B. Khorram,J Götz,Robert Vandorpe,Geoffrey N. Smith,Lili C. Kopala,Alasdair M. Barr,William G. Honer +8 more
TL;DR: Olanzapine may be effective in normalizing fronto-thalamic structural connectivity in schizophrenia and cause a significant 25% increase in anterior internal capsule volume from baseline to follow-up compared with controls.
Journal ArticleDOI
The utility of psychotropic drugs on patients with Fetal Alcohol Spectrum Disorder (FASD): a systematic review
Mansfield Mela,Udoka Okpalauwaekwe,Tara Anderson,Jamie Eng,Shawn Nomani,A. G. Ahmed,Alasdair M. Barr +6 more
TL;DR: It was showed that there are some clinical evidence displaying the validity of psychopharmacological interventions in people with FASD, which varies across the spectrum of disease severity, age, and gender.
Journal ArticleDOI
Treatment algorithm for the use of psychopharmacological agents in individuals prenatally exposed to alcohol and/or with diagnosis of fetal alcohol spectrum disorder (FASD).
Mansfield Mela,Ana Hanlon-Dearman,A. G. Ahmed,Susan D Rich,Rod Densmore,Dorothy Reid,Alasdair M. Barr,David N. Osser,Tara Anderson,Bola Suberu,Osman S. Ipsiroglu,Hasu Rajani,Christine Loock +12 more
TL;DR: The development of decision tree for use to prescribe psychotropic medications incorporated findings from previous research and the collective clinical experience of a multidisciplinary and international panel of experts who work with individuals with ND-PAE/FASD, including an algorithm specialist.